Brian Grow Organogenesis Holdings Inc. (ORGO) insider trading activity

Brian Grow is Chief Commercial Officer of Organogenesis Holdings Inc.. Currently has a direct ownership of 672,377 shares of ORGO, which is worth approximately $3.05 Million. The most recent transaction as insider was on Aug 11, 2025, when has been sold 2,173 shares (Class A Common Stock) at a price of $4.62 per share, resulting in proceeds of $10,039. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 672K

0.28% 3M change

29.1% 12M change

Total Value Held $3.05 Million

Brian Grow Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Aug 11 2025	SELL Payment of exercise price or tax liability	$10,039 $4.62 p/Share	2,173 Reduced 0.32%	672,377 Class A Common Stock
Aug 11 2025	BUY Exercise of conversion of derivative security	$10,028 $2.47 p/Share	4,060 Added 0.6%	674,550 Class A Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	183,067 Added 21.45%	670,490 Class A Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$2,427 $3.7 p/Share	656 Reduced 0.13%	487,423 Class A Common Stock
Feb 15 2025	SELL Payment of exercise price or tax liability	$121,101 $3.7 p/Share	32,730 Reduced 6.28%	488,079 Class A Common Stock
Apr 01 2024	SELL Payment of exercise price or tax liability	$5,535 $2.8 p/Share	1,977 Reduced 0.38%	520,809 Class A Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	173,469 Added 24.91%	522,786 Class A Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$2,780 $3.48 p/Share	799 Reduced 0.23%	349,317 Class A Common Stock
Feb 15 2024	SELL Payment of exercise price or tax liability	$81,269 $3.68 p/Share	22,084 Reduced 5.93%	350,116 Class A Common Stock
Apr 01 2023	SELL Payment of exercise price or tax liability	$5,129 $2.13 p/Share	2,408 Reduced 0.64%	372,200 Class A Common Stock
Feb 22 2023	BUY Grant, award, or other acquisition	-	291,009 Added 43.72%	374,608 Class A Common Stock
Feb 16 2023	SELL Payment of exercise price or tax liability	$2,197 $2.75 p/Share	799 Reduced 0.95%	83,599 Class A Common Stock
Feb 15 2023	SELL Payment of exercise price or tax liability	$9,770 $2.92 p/Share	3,346 Reduced 3.81%	84,398 Class A Common Stock
Aug 20 2022	BUY Exercise of conversion of derivative security	$1,175 $1.46 p/Share	805 Added 0.91%	87,744 Class A Common Stock
Apr 01 2022	SELL Payment of exercise price or tax liability	$15,599 $7.89 p/Share	1,977 Reduced 2.22%	86,939 Class A Common Stock
Feb 16 2022	SELL Payment of exercise price or tax liability	$6,216 $7.78 p/Share	799 Reduced 0.89%	88,916 Class A Common Stock
Feb 15 2022	BUY Grant, award, or other acquisition	-	45,143 Added 33.47%	89,715 Class A Common Stock
Apr 01 2021	SELL Payment of exercise price or tax liability	$39,204 $19.83 p/Share	1,977 Reduced 4.25%	44,572 Class A Common Stock
Feb 16 2021	BUY Grant, award, or other acquisition	-	10,782 Added 18.81%	46,549 Class A Common Stock

Brian Grow

Chief Commercial Officer

Canton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ORGO shares.

Notify only if

Value

Insider Trading

Get notified when an Organogenesis Holdings Inc. insider buys or sells ORGO shares.

Notify only if

Operation

Value

Type

News

Receive news related to Organogenesis Holdings Inc.

Track Activities on ORGO

Account